Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal ketamine for prevention of shivering after spinal anesthesia in cesarean section
IRCT20120910010800N14Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial of ketamine and bupivacaine in postanesthetic shivering (PAS) (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoint: Incidence and severity of shivering after spinal anesthesia. Started Sep 2025; status: completed.
02
Drugs
ketaminebupivacaine
03
Conditions
postanesthetic shivering (PAS)
Beyond the preview
Go deeper on IRCT20120910010800N14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120910010800N14.